Cadre Holdings, Inc. Operating Income
Cadre Holdings, Inc. (CDRE) reported Operating Income of $22.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- Cadre Holdings, Inc. operating income (loss) for the quarter ending 2026-06-30 was $22.46M, a 52.96% increase year-over-year.
- Cadre Holdings, Inc. operating income (loss) for the quarter ending 2026-03-31 was $7.49M, a 44.72% decline year-over-year.
- Cadre Holdings, Inc. operating income (loss) for the quarter ending 2025-12-31 was $20.44M, a 30.48% decline year-over-year.
- Cadre Holdings, Inc. operating income (loss) for the quarter ending 2025-09-30 was $18.67M, a 244.16% increase year-over-year.
- Cadre Holdings, Inc. operating income (loss) for fiscal 2025 was $67.35M, a 0.88% increase from fiscal 2024.
- Cadre Holdings, Inc. operating income (loss) for fiscal 2024 was $66.76M, a 18.12% increase from fiscal 2023.
- Cadre Holdings, Inc. operating income (loss) for fiscal 2023 was $56.52M, a 238.11% increase from fiscal 2022.
- Cadre Holdings, Inc. operating income (loss) for fiscal 2022 was $16.72M, a 67.68% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.46M 10-Q · filed 2026-08-05 | $29.95M 10-Q · filed 2026-08-05 | $50.39M derived: sum of 3 quarters · filed 2026-08-05 | $69.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $7.49M 10-Q · filed 2026-05-11 | $27.93M derived: sum of 2 quarters · filed 2026-05-11 | $46.60M derived: sum of 3 quarters · filed 2026-05-11 | $61.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $20.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $39.11M derived: sum of 2 quarters · filed 2026-03-10 | $53.80M derived: sum of 3 quarters · filed 2026-08-05 | $67.35M 10-K · filed 2026-03-10 |
| 2025-09-30 | $18.67M 10-Q · filed 2025-11-04 | $33.36M derived: sum of 2 quarters · filed 2026-08-05 | $46.91M 10-Q · filed 2025-11-04 | $76.31M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $14.69M 10-Q · filed 2026-08-05 | $28.24M 10-Q · filed 2026-08-05 | $57.64M derived: sum of 3 quarters · filed 2026-08-05 | $63.07M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $13.55M 10-Q · filed 2026-05-11 | $42.95M derived: sum of 2 quarters · filed 2026-05-11 | $48.38M derived: sum of 3 quarters · filed 2026-05-11 | $68.33M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $29.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $34.83M derived: sum of 2 quarters · filed 2026-03-10 | $54.78M derived: sum of 3 quarters · filed 2026-03-10 | $66.76M 10-K · filed 2026-03-10 |
| 2024-09-30 | $5.43M 10-Q · filed 2025-11-04 | $25.38M derived: sum of 2 quarters · filed 2025-11-04 | $37.36M 10-Q · filed 2025-11-04 | $50.03M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-06-30 | $19.95M 10-Q · filed 2025-08-05 | $31.93M 10-Q · filed 2025-08-05 | $44.61M derived: sum of 3 quarters · filed 2026-03-10 | $61.34M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-03-31 | $11.98M 10-Q · filed 2025-05-06 | $24.66M derived: sum of 2 quarters · filed 2026-03-10 | $41.39M derived: sum of 3 quarters · filed 2026-03-10 | $57.28M derived: sum of 4 quarters · filed 2026-03-10 |
| 2023-12-31 | $12.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $29.41M derived: sum of 2 quarters · filed 2026-03-10 | $45.30M derived: sum of 3 quarters · filed 2026-03-10 | $56.52M 10-K · filed 2026-03-10 |
| 2023-09-30 | $16.73M 10-Q · filed 2024-11-06 | $32.62M derived: sum of 2 quarters · filed 2024-11-06 | $43.84M 10-Q · filed 2024-11-06 | $56.56M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $15.89M 10-Q · filed 2024-08-09 | $27.11M 10-Q · filed 2024-08-09 | $39.83M derived: sum of 3 quarters · filed 2025-03-11 | $50.15M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $11.22M 10-Q · filed 2024-05-08 | $23.94M derived: sum of 2 quarters · filed 2025-03-11 | $34.26M derived: sum of 3 quarters · filed 2025-03-11 | $42.42M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $12.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $23.04M derived: sum of 2 quarters · filed 2025-03-11 | $31.20M derived: sum of 3 quarters · filed 2025-03-11 | $16.72M 10-K · filed 2025-03-11 |
| 2022-09-30 | $10.32M 10-Q · filed 2023-11-08 | $18.48M derived: sum of 2 quarters · filed 2023-11-08 | $3.99M 10-Q · filed 2023-11-08 | $13.31M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-06-30 | $8.16M 10-Q · filed 2023-08-08 | -$6.33M 10-Q · filed 2023-08-08 | $3.00M derived: sum of 3 quarters · filed 2024-03-12 | $14.54M derived: sum of 4 quarters · filed 2024-03-12 |
| 2022-03-31 | -$14.48M 10-Q · filed 2023-05-09 | -$5.16M derived: sum of 2 quarters · filed 2024-03-12 | $6.38M derived: sum of 3 quarters · filed 2024-03-12 | $21.80M derived: sum of 4 quarters · filed 2024-03-12 |
| 2021-12-31 | $9.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $20.86M derived: sum of 2 quarters · filed 2024-03-12 | $36.28M derived: sum of 3 quarters · filed 2024-03-12 | $51.72M 10-K · filed 2024-03-12 |
| 2021-09-30 | $11.54M 10-Q · filed 2022-11-10 | $26.96M derived: sum of 2 quarters · filed 2022-11-10 | $42.40M 10-Q · filed 2022-11-10 | $51.69M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $15.42M 10-Q · filed 2022-08-11 | $30.86M 10-Q · filed 2022-08-11 | $40.15M derived: sum of 3 quarters · filed 2022-08-11 | $52.91M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $15.43M 10-Q · filed 2022-05-16 | $24.72M derived: sum of 2 quarters · filed 2022-05-16 | $37.48M derived: sum of 3 quarters · filed 2022-05-16 | |
| 2020-12-31 | $9.29M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $22.05M derived: sum of 2 quarters · filed 2022-03-11 | $49.80M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $12.76M 10-Q · filed 2021-12-02 | $40.51M 10-Q · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |